Benjamin Coleman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Benjamin Coleman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alex C. Spyropoulos
Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, USA
2 shared publications - D'Arcy King
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Manhasset, NY United States
2 shared publications - Jeffrey Solomon
Feinstein Institutes for Medical Research, Northwell Health, 600 Community Drive, Suite 403, Manhasset, NY, 11030, United States, 1 5166001421
2 shared publications - John Chelico
Physician Enterprise, CommonSpirit Health, Chicago, IL, United States
2 shared publications - Katherine L. Dauber-Decker
Feinstein Institutes for Medical Research, Northwell Health, 600 Community Drive, Suite 403, Manhasset, NY, 11030, United States, 1 5166001421
2 shared publications - Rupert Persaud
Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, NY, United States
2 shared publications
Latest Publications
- Open Access
- 19 October 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e44065
Integrating Clinical Decision Support Into Electronic Health Record Systems Using a Novel Platform (EvidencePoint): Developmental Study
Background: Through our work, we have demonstrated how clinical decision support (CDS) tools integrated into the electronic health record (EHR) assist providers in adopting evidence-based practices. This requires confronting technical challenges that result from relying on the EHR as the foundation for tool development; for example, the individual CDS tools need to be built independently for each different EHR. Objective: The objective of our research was to build and implement an EHR-agnostic platform for integrating CDS tools, which would remove the technical constraints inherent in relying on the EHR as the foundation and enable a single set of CDS tools that can work with any EHR. Methods: We developed EvidencePoint, a novel, cloud-based, EHR-agnostic CDS platform, and we will describe the development of EvidencePoint and the deployment of its initial CDS tools, which include EHR-integrated applications for clinical use cases such as prediction of hospitalization survival for patients with COVID-19, venous thromboembolism prophylaxis, and pulmonary embolism diagnosis. Results: The results below highlight the adoption of the CDS tools, the International Medical Prevention Registry on Venous Thromboembolism-D-Dimer, the Wells’ criteria, and the Northwell COVID-19 Survival (NOCOS), following development, usability testing, and implementation. The International Medical Prevention Registry on Venous Thromboembolism-D-Dimer CDS was used in 5249 patients at the 2 clinical intervention sites. The intervention group tool adoption was 77.8% (4083/5249 possible uses). For the NOCOS tool, which was designed to assist with triaging patients with COVID-19 for hospital admission in the event of constrained hospital resources, the worst-case resourcing scenario never materialized and triaging was never required. As a result, the NOCOS tool was not frequently used, though the EvidencePoint platform’s flexibility and customizability enabled the tool to be developed and deployed rapidly under the emergency conditions of the pandemic. Adoption rates for the Wells’ criteria tool will be reported in a future publication. Conclusions: The EvidencePoint system successfully demonstrated that a flexible, user-friendly platform for hosting CDS tools outside of a specific EHR is feasible. The forthcoming results of our outcomes analyses will demonstrate the adoption rate of EvidencePoint tools as well as the impact of behavioral economics “nudges” on the adoption rate. Due to the EHR-agnostic nature of EvidencePoint, the development process for additional forms of CDS will be simpler than traditional and cumbersome IT integration approaches and will benefit from the capabilities provided by the core system of EvidencePoint.
- 19 October 2023
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 7 (1) , e44065
Open AccessIntegrating Clinical Decision Support Into Electronic Health Record Systems Using a Novel Platform (EvidencePoint): Developmental Study
Background: Through our work, we have demonstrated how clinical decision support (CDS) tools integrated into the electronic health record (EHR) assist providers in adopting evidence-based practices. This requires confronting technical challenges that result from relying on the EHR as the foundation for tool development; for example, the individual CDS tools need to be built independently for each different EHR. Objective: The objective of our research was to build and implement an EHR-agnostic platform for integrating CDS tools, which would remove the technical constraints inherent in relying on the EHR as the foundation and enable a single set of CDS tools that can work with any EHR. Methods: We developed EvidencePoint, a novel, cloud-based, EHR-agnostic CDS platform, and we will describe the development of EvidencePoint and the deployment of its initial CDS tools, which include EHR-integrated applications for clinical use cases such as prediction of hospitalization survival for patients with COVID-19, venous thromboembolism prophylaxis, and pulmonary embolism diagnosis. Results: The results below highlight the adoption of the CDS tools, the International Medical Prevention Registry on Venous Thromboembolism-D-Dimer, the Wells’ criteria, and the Northwell COVID-19 Survival (NOCOS), following development, usability testing, and implementation. The International Medical Prevention Registry on Venous Thromboembolism-D-Dimer CDS was used in 5249 patients at the 2 clinical intervention sites. The intervention group tool adoption was 77.8% (4083/5249 possible uses). For the NOCOS tool, which was designed to assist with triaging patients with COVID-19 for hospital admission in the event of constrained hospital resources, the worst-case resourcing scenario never materialized and triaging was never required. As a result, the NOCOS tool was not frequently used, though the EvidencePoint platform’s flexibility and customizability enabled the tool to be developed and deployed rapidly under the emergency conditions of the pandemic. Adoption rates for the Wells’ criteria tool will be reported in a future publication. Conclusions: The EvidencePoint system successfully demonstrated that a flexible, user-friendly platform for hosting CDS tools outside of a specific EHR is feasible. The forthcoming results of our outcomes analyses will demonstrate the adoption rate of EvidencePoint tools as well as the impact of behavioral economics “nudges” on the adoption rate. Due to the EHR-agnostic nature of EvidencePoint, the development process for additional forms of CDS will be simpler than traditional and cumbersome IT integration approaches and will benefit from the capabilities provided by the core system of EvidencePoint.
- Open Access
- 4 November 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Integrating Clinical Decision Support Into Electronic Health Record Systems Using a Novel Platform (EvidencePoint): Developmental Study (Preprint)
BACKGROUND Through our work, we have demonstrated how clinical decision support (CDS) tools integrated into the electronic health record (EHR) assist providers in adopting evidence-based practices. This requires confronting technical challenges that result from relying on the EHR as the foundation for tool development; for example, the individual CDS tools need to be built independently for each different EHR. OBJECTIVE The objective of our research was to build and implement an EHR-agnostic platform for integrating CDS tools, which would remove the technical constraints inherent in relying on the EHR as the foundation and enable a single set of CDS tools that can work with any EHR. METHODS We developed EvidencePoint, a novel, cloud-based, EHR-agnostic CDS platform, and we will describe the development of EvidencePoint and the deployment of its initial CDS tools, which include EHR-integrated applications for clinical use cases such as prediction of hospitalization survival for patients with COVID-19, venous thromboembolism prophylaxis, and pulmonary embolism diagnosis. RESULTS The results below highlight the adoption of the CDS tools, the International Medical Prevention Registry on Venous Thromboembolism-D-Dimer, the Wells’ criteria, and the Northwell COVID-19 Survival (NOCOS), following development, usability testing, and implementation. The International Medical Prevention Registry on Venous Thromboembolism-D-Dimer CDS was used in 5249 patients at the 2 clinical intervention sites. The intervention group tool adoption was 77.8% (4083/5249 possible uses). For the NOCOS tool, which was designed to assist with triaging patients with COVID-19 for hospital admission in the event of constrained hospital resources, the worst-case resourcing scenario never materialized and triaging was never required. As a result, the NOCOS tool was not frequently used, though the EvidencePoint platform’s flexibility and customizability enabled the tool to be developed and deployed rapidly under the emergency conditions of the pandemic. Adoption rates for the Wells’ criteria tool will be reported in a future publication. CONCLUSIONS The EvidencePoint system successfully demonstrated that a flexible, user-friendly platform for hosting CDS tools outside of a specific EHR is feasible. The forthcoming results of our outcomes analyses will demonstrate the adoption rate of EvidencePoint tools as well as the impact of behavioral economics “nudges” on the adoption rate. Due to the EHR-agnostic nature of EvidencePoint, the development process for additional forms of CDS will be simpler than traditional and cumbersome IT integration approaches and will benefit from the capabilities provided by the core system of EvidencePoint.
- 4 November 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIntegrating Clinical Decision Support Into Electronic Health Record Systems Using a Novel Platform (EvidencePoint): Developmental Study (Preprint)
BACKGROUND Through our work, we have demonstrated how clinical decision support (CDS) tools integrated into the electronic health record (EHR) assist providers in adopting evidence-based practices. This requires confronting technical challenges that result from relying on the EHR as the foundation for tool development; for example, the individual CDS tools need to be built independently for each different EHR. OBJECTIVE The objective of our research was to build and implement an EHR-agnostic platform for integrating CDS tools, which would remove the technical constraints inherent in relying on the EHR as the foundation and enable a single set of CDS tools that can work with any EHR. METHODS We developed EvidencePoint, a novel, cloud-based, EHR-agnostic CDS platform, and we will describe the development of EvidencePoint and the deployment of its initial CDS tools, which include EHR-integrated applications for clinical use cases such as prediction of hospitalization survival for patients with COVID-19, venous thromboembolism prophylaxis, and pulmonary embolism diagnosis. RESULTS The results below highlight the adoption of the CDS tools, the International Medical Prevention Registry on Venous Thromboembolism-D-Dimer, the Wells’ criteria, and the Northwell COVID-19 Survival (NOCOS), following development, usability testing, and implementation. The International Medical Prevention Registry on Venous Thromboembolism-D-Dimer CDS was used in 5249 patients at the 2 clinical intervention sites. The intervention group tool adoption was 77.8% (4083/5249 possible uses). For the NOCOS tool, which was designed to assist with triaging patients with COVID-19 for hospital admission in the event of constrained hospital resources, the worst-case resourcing scenario never materialized and triaging was never required. As a result, the NOCOS tool was not frequently used, though the EvidencePoint platform’s flexibility and customizability enabled the tool to be developed and deployed rapidly under the emergency conditions of the pandemic. Adoption rates for the Wells’ criteria tool will be reported in a future publication. CONCLUSIONS The EvidencePoint system successfully demonstrated that a flexible, user-friendly platform for hosting CDS tools outside of a specific EHR is feasible. The forthcoming results of our outcomes analyses will demonstrate the adoption rate of EvidencePoint tools as well as the impact of behavioral economics “nudges” on the adoption rate. Due to the EHR-agnostic nature of EvidencePoint, the development process for additional forms of CDS will be simpler than traditional and cumbersome IT integration approaches and will benefit from the capabilities provided by the core system of EvidencePoint.
- Open Access
Graph Reordering for Cache-Efficient Near Neighbor Search
Graph search is one of the most successful algorithmic trends in near neighbor search. Several of the most popular and empirically successful algorithms are, at their core, a simple walk along a pruned near neighbor graph. Such algorithms consistently perform at the top of industrial speed benchmarks for applications such as embedding search. However, graph traversal applications often suffer from poor memory access patterns, and near neighbor search is no exception to this rule. Our measurements show that popular search indices such as the hierarchical navigable small-world graph (HNSW) can have poor cache miss performance. To address this problem, we apply graph reordering algorithms to near neighbor graphs. Graph reordering is a memory layout optimization that groups commonly-accessed nodes together in memory. We present exhaustive experiments applying several reordering algorithms to a leading graph-based near neighbor method based on the HNSW index. We find that reordering improves the query time by up to 40%, and we demonstrate that the time needed to reorder the graph is negligible compared to the time required to construct the index.
Open AccessGraph Reordering for Cache-Efficient Near Neighbor Search
Graph search is one of the most successful algorithmic trends in near neighbor search. Several of the most popular and empirically successful algorithms are, at their core, a simple walk along a pruned near neighbor graph. Such algorithms consistently perform at the top of industrial speed benchmarks for applications such as embedding search. However, graph traversal applications often suffer from poor memory access patterns, and near neighbor search is no exception to this rule. Our measurements show that popular search indices such as the hierarchical navigable small-world graph (HNSW) can have poor cache miss performance. To address this problem, we apply graph reordering algorithms to near neighbor graphs. Graph reordering is a memory layout optimization that groups commonly-accessed nodes together in memory. We present exhaustive experiments applying several reordering algorithms to a leading graph-based near neighbor method based on the HNSW index. We find that reordering improves the query time by up to 40%, and we demonstrate that the time needed to reorder the graph is negligible compared to the time required to construct the index.
- Open Access
SARNAclust: Semi-automatic detection of RNA protein binding motifs from immunoprecipitation data
RNA-protein binding is critical to gene regulation, controlling fundamental processes including splicing, translation, localization and stability, and aberrant RNA-protein interactions are known to play a role in a wide variety of diseases. However, molecular understanding of RNA-protein interactions remains limited, and in particular identification of the RNA motifs that bind proteins has long been a difficult problem. To address this challenge, we have developed a novel semi-automatic algorithm, SARNAclust, to computationally identify combined structure/sequence motifs from immunoprecipitation data. SARNAclust is, to our knowledge, the first unsupervised method that can identify RNA motifs at full structural resolution while also being able to simultaneously deconvolve multiple motifs. SARNAclust makes use of a graph kernel to evaluate similarity between sequence/structure objects, and provides the ability to isolate the impact of specific features through the bulge graph formalism. SARNAclust includes a key method for predicting RNA secondary structure at CLIP peaks, RNApeakFold, which we have verified to be effective on synthetic motif data. We applied SARNAclust to 30 ENCODE eCLIP datasets, identifying known motifs and novel predictions. Notably, we predicted a new motif for the protein ILF3 similar to that for the splicing factor hnRNPC, providing evidence for interaction between these two proteins. To validate our predictions, we performed a directed RNA bind-n-seq assay for two proteins: ILF3 and SLBP, in each case revealing the effectiveness of SARNAclust in predicting RNA sequence and structure elements important to protein binding. Availability: https://github.com/idotu/SARNAclust
Open AccessSARNAclust: Semi-automatic detection of RNA protein binding motifs from immunoprecipitation data
RNA-protein binding is critical to gene regulation, controlling fundamental processes including splicing, translation, localization and stability, and aberrant RNA-protein interactions are known to play a role in a wide variety of diseases. However, molecular understanding of RNA-protein interactions remains limited, and in particular identification of the RNA motifs that bind proteins has long been a difficult problem. To address this challenge, we have developed a novel semi-automatic algorithm, SARNAclust, to computationally identify combined structure/sequence motifs from immunoprecipitation data. SARNAclust is, to our knowledge, the first unsupervised method that can identify RNA motifs at full structural resolution while also being able to simultaneously deconvolve multiple motifs. SARNAclust makes use of a graph kernel to evaluate similarity between sequence/structure objects, and provides the ability to isolate the impact of specific features through the bulge graph formalism. SARNAclust includes a key method for predicting RNA secondary structure at CLIP peaks, RNApeakFold, which we have verified to be effective on synthetic motif data. We applied SARNAclust to 30 ENCODE eCLIP datasets, identifying known motifs and novel predictions. Notably, we predicted a new motif for the protein ILF3 similar to that for the splicing factor hnRNPC, providing evidence for interaction between these two proteins. To validate our predictions, we performed a directed RNA bind-n-seq assay for two proteins: ILF3 and SLBP, in each case revealing the effectiveness of SARNAclust in predicting RNA sequence and structure elements important to protein binding. Availability: https://github.com/idotu/SARNAclust